Texas Health & Safety Legal News

FDA Warning: Counterfeit Internet Drugs

The FDA received information showing that 24 apparently related websites operated outside the US may be involved in the distribution of counterfeit prescription drugs. On three occasions during recent months, consumers obtained counterfeit versions of Xenical 120mg Capsules, a drug used to help obes

By The Legal Examiner

/ 2 May 2007

Permanent Injunction against PharmaFab Inc., PFab LP prescription and otc drugs

FDA announced the entry of a Consent Decree of Permanent Injunction against PharmaFab Inc., its subsidiary, PFab LP, and two company officials, to stop the illegal manufacture and distribution of prescription and over-the-counter drug products. The products are illegal because they are not produced

By The Legal Examiner

/ 26 Apr 2007

FDA RECALL – V.MAX Erectile Dysfunction (ED) supplement

From MedWatch – The FDA Safety Information and Adverse Event Reporting ProgramBarodon SF and FDA notified consumers and healthcare professionals of a voluntary nationwide recall of a supplement product sold under the name V.MAX. Lab analysis by FDA of product samples found the product contains Amino

By The Legal Examiner

/ 19 Mar 2007

Warning to Cardiologists About Drug-Eluting Stents

physicians must be cautious in how they use drug-eluting stentsA statement warning cardiologists when treating arteries with drug-eluting stents was issued by The Society for Cardiovascular Angiography and Interventions (SCAI).The SCAI supports use of drug-eluting stents, but stated that physicians

By The Legal Examiner

/ 31 Jan 2007

Fosamax Lawsuit Possibility

A report in Medical News Today outlined some of the dangers or Fosamax:The following information has been reported related to Fosamax:– Fosamax causes a rare disease called osteonecrosis of the jaw, (ONJ)– New cases are cropping up each day where a patient’s jawbone rots and dies– The American Assoc

By The Legal Examiner

/ 23 Jan 2007

Can Cholesterol Drugs Cause Parkinson's?

A new study has suggested a connection between cholesterol-lowering drugs (statins) and an increased risk of Parkinson’s disease. Researchers at the University of North Carolina found that patients with low levels of LDL cholesterol are upward of three and a half times more likely to develop Parkins

By The Legal Examiner

/ 16 Jan 2007

Parrkinson's Drugs Could Cause Valve Risk

About one in four patients taking pergolide or cabergoline show signs of heart-valve damage according to two studies.A U.S. official to call for a halt in the use of two drugs used for Parkinson’s disease, pergolide and cabergoline due to an increased risk of heart-valve damage.Patients who took per

By The Legal Examiner

/ 12 Jan 2007

Tamiflu Might Receive New Labeling Due to Reported Deaths and "Bizarre Behavior"

Uh-oh – it looks as though the makers of Tamiflu could have a potential controversy on their hands. Due to new reports of “bizarre” behavior and deaths related to falls and other similar behavior, new warnings may be placed on Tamiflu labels. Doctors and parents are being told to watch for signs of

By The Legal Examiner

/ 16 Nov 2006

Lawsuit Claims Ortho Evra Birth Control Patch Caused Blood Clots and Miscarriage

A Plano, Texas woman who suffered a miscarriage and developed potentially life-threatening blood clots after using the Ortho Evra birth control patch has filed a federal lawsuit against drug manufacturing giant Johnson & Johnson inMarshall, Texas.According to an article on PR Newswire, Elizabeth Bar

By The Legal Examiner

/ 13 Sep 2006

Merck had Another Bad Week – Two More Plaintiff Victories in Vioxx Lawsuits

Merck & Co. was hit with two major legal setbacks over the withdrawn painkiller Vioxx on Thursday when a federal jury in New Orleans ordered the drugmaker to pay $51 million to a heart attack victim, and a state judge in New Jersey overturned a November verdict favoring the company. In New Orleans,

By The Legal Examiner

/ 28 Aug 2006

Merck Facing Potential New Lawsuits With Fosamax

As Merck & Co. defends itself against a deluge of litigation involving its pain reliever Vioxx, the pharmaceutical giant also is fielding the first of what could be another wave of lawsuits involving Fosamax, its second-biggest seller. The emerging litigation targeting the osteoporosis drug, still i

By The Legal Examiner

/ 11 Jul 2006

FDA Issues Warning Regarding Abortion Pill Risks

The recent deaths of two women, coming after both had used the abortion pill Mifepristone (also known as RU-486), has prompted the FDA to issues fresh warnings concerning the use of the drug. These most recent deaths follow at least four known previous deaths linked to the drug.RU-486 is approved to

By The Legal Examiner

/ 22 Mar 2006